FDA Approves Supplemental Applications for TRELSTAR
The FDA has approved supplemental applications for TRELSTAR, a triptorelin pamoate product.
Asset / Drug
Drug and asset intelligence for Verity with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Hormonal Therapy
No catalysts indexed for this entity yet.
July 3, 2026 · N/A
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.